(Q42637870)
Statements
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer (English)
Susan Wilner
Sethupathi R Muthuramalingam
Martin Foster
Jeremy P Braybrooke
Cheng Han
Susan Hoare
Denis C Talbot
Trivadi S Ganesan